Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Maternal Care, Gene Expression, and the Transmission of Individual Differences in Stress Reactivity Across Generations
2001 Standout
Light Microscopic Autoradiographical Analysis of [125I]Epidermal Growth Factor Binding in Basal Cell Epithelioma and Squamous Cell Carcinoma of the Skin
1993
Untangling the ErbB signalling network
2001 Standout
Basal cell carcinomas: attack of the hedgehog
2008 Standout
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice
2006 StandoutNobel
Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system
1993
Mechanisms of Thrombus Formation
2008 Standout
Cellular microparticles: new players in the field of vascular disease?
2004
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Anatomy and regulation of the central melanocortin system
2005 Standout
Elevated Platelet Microparticle Levels in Nonvalvular Atrial Fibrillation
2007
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
Neural regulation of endocrine and autonomic stress responses
2009 Standout
Clavilactones, a novel class of tyrosine kinase inhibitors of fungal origin
2000
Exercise Standards for Testing and Training
2013 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice
2007 StandoutNobel
Facilitation of ACTH secretion by morphine is mediated by activation of CRF releasing neurons and sympathetic neuronal pathways
1989
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
2009 Standout
Platelet-Derived MRP-14 Induces Monocyte Activation in Patients With Symptomatic Peripheral Artery Disease
2018
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Regulation of ovarian function by catecholestrogens: Current concepts
1989
Platelet Activation and Atherothrombosis
2007 Standout
Sex differences in pain and analgesia: the role of gonadal hormones
2004
The golden age: gold nanoparticles for biomedicine
2011 Standout
Androgen Regulation of Proopiomelanocortin Gene Expression and Peptide Content in the Basal Hypothalamus*
1989
Exercise training enhances endogenous fibrinolysis in peripheral arterial disease
2004
The potential role of platelet microparticles in atherosclerosis
2005
Epidermal growth factor receptor and lipid membrane components in human lung cancers
1993
Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer.
1993
The immunology of stroke: from mechanisms to translation
2011 Standout
P-selectin and leukocyte microparticles are associated with venous thrombogenesis
2003
Integrated Nanoparticle–Biomolecule Hybrid Systems: Synthesis, Properties, and Applications
2004 Standout
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
Mechanisms of hyperbaric oxygen and neuroprotection in stroke
2005
Stress-Induced Suppression of Luteinizing Hormone Concentrations in Wild Baboons: Role of Opiates*
1988
Complement activation on platelets: Implications for vascular inflammation and thrombosis
2010
Neurocircuitry of stress: central control of the hypothalamo–pituitary–adrenocortical axis
1997 Standout
Correlating EGFR Expression with Receptor-Binding Properties and Internalization of 64Cu-DOTA-Cetuximab in 5 Cervical Cancer Cell Lines
2008
Gold Nanorods: From Synthesis and Properties to Biological and Biomedical Applications
2009 Standout
Transient Receptor Potential Cation Channels in Disease
2007 Standout
Temperature Sensitivity of Dopaminergic Neurons of the Substantia Nigra Pars Compacta: Involvement of Transient Receptor Potential Channels
2005
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
Gold nanoparticles in biomedical applications: recent advances and perspectives
2011 Standout
Evidence for the Involvement of Endogenous Opioids in the Inhibition of Luteinizing Hormone by Corticotropin-Releasing Factor*
1988
Significance of epidermal growth factor receptor in advanced ovarian cancer.
1992
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
A sensitivity scale for targeting T cells with chimeric antigen receptors (CARs) and bispecific T-cell Engagers (BiTEs)
2012
Receptors for epidermal growth factor and steroid hormones in primary laryngeal tumors
1991
Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications
1995
Immunohistochemical demonstration of elevated expression of epidermal growth factor receptor in the neoplastic changes of cervical squamous epithelium
1992
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
Head and Neck Cancer
2001 Standout
Expression of Epidermal Growth Factor Receptor in Laryngeal Dysplasia and Carcinoma
1990
Peripheral vascular disease and Virchow's triad for thrombogenesis
2002
Animal models of implantation
2004
The Complex Role of Estrogens in Inflammation
2007 Standout
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
The role of platelets in decrypting monocyte tissue factor
2001
Nonbleaching Fluorescence of Gold Nanoparticles and Its Applications in Cancer Cell Imaging
2008
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Invited Review: Cardiovascular protective effects of 17β-estradiol metabolites
2001
Natural Product Synthesis Using Multicomponent Reaction Strategies
2009 Standout
Expression of c-myc, Epidermal Growth Factor Receptor and c-erbB-2 in Human Endometrial Carcinoma and Cervical Adenocarcinoma.
1991
Arcuate Nucleus and Preoptic Area Involvement in Beta‐Endorphin‐lnduced Release of Prolactin in Conscious Ovariectomized Rats†
1989
Calculated Absorption and Scattering Properties of Gold Nanoparticles of Different Size, Shape, and Composition: Applications in Biological Imaging and Biomedicine
2006 Standout
Prognostic value of epidermal growth factor receptor expression in cervical carcinoma.
1993
Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us?
1999 Standout
Structure formation of liquid‐crystalline isotropic AB block copolymers in nematic solvents
1995
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Noble Metals on the Nanoscale: Optical and Photothermal Properties and Some Applications in Imaging, Sensing, Biology, and Medicine
2008 Standout
Maternal Care, Hippocampal Glucocorticoid Receptors, and Hypothalamic-Pituitary-Adrenal Responses to Stress
1997 StandoutScience
A review of brain aromatase cytochrome P450
1996
How Do Glucocorticoids Influence Stress Responses? Integrating Permissive, Suppressive, Stimulatory, and Preparative Actions*
2000 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Nanostructured Plasmonic Sensors
2008 Standout
Self-Assembly Synthesis, Tumor Cell Targeting, and Photothermal Capabilities of Antibody-Coated Indocyanine Green Nanocapsules
2010
Synergistic interaction between gefitinib (Iressa, ZD1839) and paclitaxel against human gastric carcinoma cells
2004
Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles.
2003
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Micellization of block copolymers
2003 Standout
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Endothelial Function and Dysfunction
2007 Standout
Works of Doris Pfeiffer being referenced
Clinical Implications of the EGF Receptor/Ligand System for Tumor Progression and Survival in Gastrointestinal Carcinomas: Evidence for New Therapeutic Options
2003
Low-dose flunarizine does not affect short-term fetal circulatory responses to acute asphyxia in sheep near term
1999
Coagulation, Fibrinolysis and Platelet P-selectin Expression in Peripheral Vascular Disease
2001
Quantitative determination of the epidermal growth factor receptor in cervical cancer and normal cervical epithelium by 2-color flow cytometry: Evidence for down-regulation in cervical cancer
1997
Clinical implications of the epidermal growth factor receptor in the squamous cell carcinoma of the uterine cervix
1989
P-Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease
2000
Opiate suppression of LH secretion involves central receptors different from those mediating opiate effects on prolactin secretion
1987
Metabolism of exogenous 4- and 2-hydroxyestradiol in the human male
1987
mRNA expression of ligands of the epidermal-growth-factor-receptor in the uterus
1997
Effects of Mild Hypothermia on Metabolic Disturbances in Fetal Hippocampal Slices After Oxygen/Glucose Deprivation Depend on Depth and Time Delay of Cooling
2001
Haemostatic derangement in advanced peripheral occlusive arterial disease.
1999
Are catechol oestrogens obligatory mediators of oestrogen action in the central nervous system? I. Characterization of pharmacological probes with different receptor binding affinities and catechol oestrogen formation rates
1986
CENTRAL KAPPA- AND MU-OPIATE RECEPTORS MEDIATE ACTH-RELEASE IN RATS.
1985
Predominant involvement of mu- rather than delta- or kappa-opiate receptors in LH secretion
1983
Are catechol oestrogens obligatory mediators of oestrogen action in the central nervous system? II. Potencies of natural and synthetic oestrogens for induction of gonadotrophin release and female sexual behaviour in the rat
1986
Kristallin‐flüssige trans‐4‐n‐Alkylcyclohexancarbonsäure‐[4‐cyanophenylester]
1977
Opioid Modulation of LHRH Release in vitro Depends upon Levels of Testosterone in vivo
1986